Skip to main content
. Author manuscript; available in PMC: 2016 Apr 15.
Published in final edited form as: Int J Cancer. 2014 Sep 29;136(8):1967–1975. doi: 10.1002/ijc.29225

Figure 4.

Figure 4

Downregulation of the PI3K pathway and Akt activity after cabozantinib treatment. (A) A depiction of the PI3K pathway after 3 days of treatment with cabozantinib: red shows genes that are downregulated. (B) Evaluation of Akt activation by western blot in 4 CRC sensitive explants. Cabozantinib inhibited Akt activation in CRC explants.